Professor Hugh Barrett

Crawley (Australia)

Follow

Contributor content

Evolocumab lowers plasma Lp(a) concentration by two kinetic modes of action: From the FLOREY Study

Presentation

Evolocumab lowers plasma Lp(a) concentration by two kinetic modes of action: From the FLOREY Study

ESC 365 is supported by

novartis

Explore sponsored resources